The Importance of Complete Pathologic Response After Neoadjuvant Systemic Treatment in Breast Cancer Research and Practice: Reply

被引：0
|
作者：
Julie A. Margenthaler
机构：
[1] Washington University School of Medicine,Department of Surgery
来源：
World Journal of Surgery | 2010年 / 34卷
关键词：
Breast Cancer; Complete Pathologic Response; Primary Breast Tumor; Breast Cancer Research; Nodal Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1986 / 1986
相关论文
共 50 条
  • [31] Intelligent vacuum-assisted breast biopsy to identify breast cancer patients with pathologic complete response after neoadjuvant systemic treatment for omission of breast and axillary surgery
    Pfob, Andre
    Sidey-Gibbons, Chris
    Rauch, Geraldine
    Thomas, Bettina
    Schaefgen, Benedikt
    Kuemmel, Sherko
    Reimer, Toralf
    Hahn, Markus
    Thill, Marc
    Blohmer, Jens-Uwe
    Hackmann, John
    Malter, Wolfram
    Bekes, Inga
    Friedrichs, Kay
    Wojcinski, Sebastian
    Joos, Sylvie
    Paepke, Stefan
    Degenhardt, Tom
    Rom, Joachim
    Rody, Achim
    Grosse, Regina
    van Mackelenbergh, Marion
    Reinisch, Mattea
    Karsten, Maria
    Golatta, Michael
    Heil, Joerg
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [32] Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
    Zhu, Jiujun
    Li, Jianbin
    Fan, Zhimin
    Wang, Haibo
    Zhang, Jianguo
    Yin, Yongmei
    Fu, Peifen
    Geng, Cuizhi
    Jin, Feng
    Jiang, Zefei
    Liu, Zhenzhen
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [33] Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: Importance of histologic type and grade
    Sturtz, DE
    Schott, AF
    Kleer, CG
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 48A - 48A
  • [34] Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: Importance of histologic type and grade
    Sturtz, DE
    Schott, AF
    Kleer, CG
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 48A - 48A
  • [35] Neoadjuvant treatment for breast cancer patients in a Venezuelan breast center. Pathologic complete response: is it worth it?
    Acosta-Marin, V.
    Acosta Freites, V.
    Ramirez, A.
    Marin, C. E.
    Contreras, A.
    Longobardi, I.
    Martinez, O.
    Maldonado, V.
    Acosta, M.
    Perez Fuentes, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 175 : S62 - S63
  • [36] Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’
    Takeo Fujii
    Naoto T Ueno
    [J]. British Journal of Cancer, 2017, 116 : e11 - e11
  • [37] Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study
    Armstrong, Dawn
    Raissouni, Soundouss
    Hiller, Julie Price
    Mercer, Jamison
    Powel, Erin
    MacLean, Anthony
    Jiang, Maria
    Doll, Corinne
    Goodwin, Rachel
    Batuyong, Eugene
    Zhou, Kevin
    Monzon, Jose G.
    Tang, Patricia A.
    Heng, Daniel Y.
    Cheung, Winson Y.
    Vickers, Michael M.
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 291 - 295
  • [38] QUANTIFYING THE BENEFIT OF A PATHOLOGIC COMPLETE RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER
    Scheer, Richard V.
    Fakiris, Achilles J.
    Johnstone, Peter A. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 996 - 1001
  • [39] Predictors of pathologic complete response after neoadjuvant treatment for rectal cancer: A multicenter study
    Armstrong, Dawn Elizabeth
    Raissouni, Soundouss
    Hiller, Julie A. Price
    Mercer, Jamison
    Powell, Erin Diana
    MacLean, Anthony
    Jiang, Maria
    Doll, Corinne M.
    Goodwin, Rachel Anne
    Batuyong, Eugene
    Zhou, Kevin
    Monzon, Jose Gerard
    Tang, Patricia
    Heng, Daniel Yick Chin
    Cheung, Winson Y.
    Vickers, Michael M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [40] Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''
    Fujii, Takeo
    Ueno, Naoto T.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e11 - e11
12345